INTERNATIONAL PATENT: UNIVERSITY OF HOUSTON SYSTEM, TRACT PHARMACEUTICALS, INC. FILES APPLICATION FOR "COMBINATION OF IAP INHIBITORS AND CELLULAR KINASE INHIBITORS, SUCH AS PONATINIB, FOR USE IN THE TREATMENT OF CANCER OR PULMONARY DISEASES, SUCH AS COPD, CYSTIC FIBROSIS, PULMONARY FIBROSIS AND COVID-19"

GENEVA, May 6 -- UNIVERSITY OF HOUSTON SYSTEM (4800 Calhoun RoadHouston, Texas 77204), TRACT PHARMACEUTICALS, INC. (29 South Main StreetSte. 305West Hartford, Connecticut 06107) filed a patent application (PCT/US2024/052562) for "COMBINATION OF IAP INHIBITORS AND CELLULAR KINASE INHIBITORS, SUCH AS PONATINIB, FOR USE IN THE TREATMENT OF CANCER OR PULMONARY DISEASES, SUCH AS COPD, CYSTIC FIBROSIS, PULMONARY FIBROSIS AND COVID-19" on Oct 23, 2024. With publication no. WO/2025/090605, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inven...